tirzepatide microdosing side effects Program There is no peer-reviewed scientific

While injectables remain a cornerstone of the market, Eli Lilly and its rivals are also turning their attention to pill versions of the drugs: In December, the Food and Drug Administration approved the first GLP-1 weight-loss pill: Novo Nordisk's Wegovy

If we can kind of like tease out what is the effect of weight loss versus what is the direct effect of these medications on the upper airway, that will be very interesting. The most common side effects of GLP-1 drugs, including tirzepatide, are nausea, vomiting, diarrhea and constipation

Unmet treatment needs in migraine: Results of the OVERCOME (US) study

What explains the differences between the values